Company / Total Debt
Arcadia Biosciences, Inc. Total Debt History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$2.1M
FY2020
5-year range
-
FY2016-FY2020
Trend
-
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $25M to $2M over the past 4 years.
Based on SEC 10-K filings.
$2M in FY2020.
Improved from $25M to $2M over the past 4 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $2.1M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $25.1M | +0.8% |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026